1.
Menotti M, Ambrogio C, Cheong T-C, et al. Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Nat Med. 2019;25(1):130-140. doi:10.1038/s41591-018-0262-9.
1.
Fernández E, Collins MO, Frank RAW, et al. Arc Requires PSD95 for Assembly into Postsynaptic Complexes Involved with Neural Dysfunction and Intelligence. Cell Rep. 2017;21(3):679-691. doi:10.1016/j.celrep.2017.09.045.
1.
Ting JT, Peça J, Feng G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu Rev Neurosci. 2012;35:49-71. doi:10.1146/annurev-neuro-062111-150442.
1.
Urgaonkar S, La Pierre HS, Meir I, Lund H, Raychaudhuri D, Shaw JT. Synthesis of antimicrobial natural products targeting FtsZ: (+/-)-dichamanetin and (+/-)-2’ ’’-hydroxy-5’ ’-benzylisouvarinol-B. Org Lett. 2005;7(25):5609-12. doi:10.1021/ol052269z.
1.
Fancy SPJ, Harrington EP, Yuen TJ, et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci. 2011;14(8):1009-16. doi:10.1038/nn.2855.
1.
Raj T, Shulman JM, Keenan BT, et al. Alzheimer disease susceptibility loci: evidence for a protein network under natural selection. Am J Hum Genet. 2012;90(4):720-6. doi:10.1016/j.ajhg.2012.02.022.
1.
Dauber A, Lafranchi SH, Maliga Z, et al. Novel microcephalic primordial dwarfism disorder associated with variants in the centrosomal protein ninein. J Clin Endocrinol Metab. 2012;97(11):E2140-51. doi:10.1210/jc.2012-2150.
1.
Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506(7487):185-90. doi:10.1038/nature12975.
1.
Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506(7487):179-84. doi:10.1038/nature12929.
1.
Ahmed MY, Chioza BA, Rajab A, et al. Loss of PCLO function underlies pontocerebellar hypoplasia type III. Neurology. 2015;84(17):1745-50. doi:10.1212/WNL.0000000000001523.